S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 207 SEK 6.15%
Market Cap: 1.9B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stille AB
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Other Long-Term Assets
kr33.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
20%
Elekta AB (publ)
STO:EKTA B
Other Long-Term Assets
kr828m
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Other Long-Term Assets
kr14.7m
CAGR 3-Years
-23%
CAGR 5-Years
12%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Other Long-Term Assets
kr1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-64%
Getinge AB
STO:GETI B
Other Long-Term Assets
kr998m
CAGR 3-Years
-12%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Other Long-Term Assets
kr558m
CAGR 3-Years
24%
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.9B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
282.04 SEK
Undervaluation 27%
Intrinsic Value
Price
S

See Also

What is Stille AB's Other Long-Term Assets?
Other Long-Term Assets
33.3m SEK

Based on the financial report for Sep 30, 2024, Stille AB's Other Long-Term Assets amounts to 33.3m SEK.

What is Stille AB's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
20%

Over the last year, the Other Long-Term Assets growth was 6 604%.

Back to Top